POTOMAC, MARYLAND / ACCESS Newswire / February 24, 2026 / IGC Pharma, Inc. (NYSE American:IGC) (“IGC” or the “Company”), today announced that Ascendiant Capital Markets has issued an updated equity research report covering the Compa…
Author: IGC Pharma, Inc.
IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial
– Practice integrated neurology network expands enrollment capacity – POTOMAC, MARYLAND / ACCESS Newswire / February 23, 2026 / IGC Pharma, Inc. (NYSE American:IGC) (“IGC” or the “Company”), today announced the addition of Visionary…